1. Home
  2. TXT vs NUWE Comparison

TXT vs NUWE Comparison

Compare TXT & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXT
  • NUWE
  • Stock Information
  • Founded
  • TXT 1923
  • NUWE 1999
  • Country
  • TXT United States
  • NUWE United States
  • Employees
  • TXT N/A
  • NUWE N/A
  • Industry
  • TXT Aerospace
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • TXT Industrials
  • NUWE Health Care
  • Exchange
  • TXT Nasdaq
  • NUWE Nasdaq
  • Market Cap
  • TXT N/A
  • NUWE 3.9M
  • IPO Year
  • TXT N/A
  • NUWE N/A
  • Fundamental
  • Price
  • TXT $69.02
  • NUWE $1.01
  • Analyst Decision
  • TXT Hold
  • NUWE Strong Buy
  • Analyst Count
  • TXT 9
  • NUWE 1
  • Target Price
  • TXT $87.33
  • NUWE $17.00
  • AVG Volume (30 Days)
  • TXT 1.7M
  • NUWE 70.5K
  • Earning Date
  • TXT 04-24-2025
  • NUWE 05-13-2025
  • Dividend Yield
  • TXT 0.11%
  • NUWE N/A
  • EPS Growth
  • TXT N/A
  • NUWE N/A
  • EPS
  • TXT 4.44
  • NUWE N/A
  • Revenue
  • TXT $13,873,000,000.00
  • NUWE $8,740,000.00
  • Revenue This Year
  • TXT $7.85
  • NUWE $22.96
  • Revenue Next Year
  • TXT $4.52
  • NUWE $29.97
  • P/E Ratio
  • TXT $15.79
  • NUWE N/A
  • Revenue Growth
  • TXT 0.57
  • NUWE N/A
  • 52 Week Low
  • TXT $57.70
  • NUWE $0.75
  • 52 Week High
  • TXT $94.57
  • NUWE $12.60
  • Technical
  • Relative Strength Index (RSI)
  • TXT 55.39
  • NUWE 53.57
  • Support Level
  • TXT $64.05
  • NUWE $0.87
  • Resistance Level
  • TXT $66.83
  • NUWE $1.06
  • Average True Range (ATR)
  • TXT 2.36
  • NUWE 0.08
  • MACD
  • TXT 0.81
  • NUWE 0.02
  • Stochastic Oscillator
  • TXT 96.05
  • NUWE 79.88

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: